These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23830349)

  • 21. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.
    Kim HS; Kim GY; Kim YW; Park YK; Song JY; Lim SJ
    Histopathology; 2010 May; 56(6):708-19. PubMed ID: 20546336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
    Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
    Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
    Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of beta-catenin, E-cadherin, and P-cadherin expressions in neoplastic progression of colorectal mucosa: an immunohistochemical study.
    Savas B; Ensari A; Percinel S; Kuzu I; Kuzu MA; Bektas M; Cetinkaya H; Kursun N
    Acta Gastroenterol Belg; 2007; 70(4):339-44. PubMed ID: 18330089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo.
    Sellin JH; Umar S; Xiao J; Morris AP
    Cancer Res; 2001 Apr; 61(7):2899-906. PubMed ID: 11306465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.
    Lee HJ; Lee OJ; Jang KT; Bae YK; Chung JY; Eom DW; Kim JM; Yu E; Hong SM
    Am J Clin Pathol; 2013 Feb; 139(2):167-76. PubMed ID: 23355201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-catenin and E-cadherin tissue "content" as prognostic markers in left-side colorectal cancer.
    Martinez NP; Kanno DT; Pereira JA; Cardinalli IA; Priolli DG
    Cancer Biomark; 2010-2011; 8(3):129-35. PubMed ID: 22012768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
    Hu X; Ruan Y; Cheng F; Yu W; Zhang X; Larré S
    Int J Urol; 2011 Sep; 18(9):630-7. PubMed ID: 21672035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disturbed expression of E-cadherin, beta-catenin and tight junction proteins in colon carcinoma is unrelated to growth pattern and genetic polymorphisms.
    Hahn-Strömberg V; Edvardsson H; Bodin L; Franzén L
    APMIS; 2008 Apr; 116(4):253-62. PubMed ID: 18397460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-catenin and E-cadherin expression in salivary gland tumors.
    Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.
    Bravou V; Klironomos G; Papadaki E; Taraviras S; Varakis J
    J Pathol; 2006 Jan; 208(1):91-9. PubMed ID: 16278819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A change in the expression of membrane-associated proteins and cytoplasmic actin isoforms in the progression of human colon tumors].
    Novikova MV; Rybko VA; Kochatkov AV; Khromova NV; Bogomazova SY; Dugina VB; Lyadov VK; Kopnin PB
    Arkh Patol; 2017; 79(2):15-21. PubMed ID: 28418353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
    Park SS; Kim JE; Kim YA; Kim YC; Kim SW
    Histopathology; 2005 Dec; 47(6):625-30. PubMed ID: 16324201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of E-cadherin and beta-catenin in oral squamous cell carcinomas of tongue: correlation with the clinicopathologic features and patient prognosis].
    Zhu R; Jiang XY; Song XL; Zhang W; Chen S; Liu LK
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):295-8. PubMed ID: 20654247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
    Joo YE; Rew JS; Park CS; Kim SJ
    Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
    Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
    Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.